Symptoms may include rash, itching, dizziness, swelling of the face or throat, or difficulty breathing
Common Community-Reported Side Effects Nausea, diarrhea, constipation, vomiting (retatrutide-driven, dose-dependent)
doi: 10.1038/s41586-019-1705-2 94 GuoXLiuFDengJDaiPQinYLiZet al
Consistent with recent commentaries, clinicians should encourage prompt evaluation of visual symptoms and consider ocular risk factors (eg, optic nerve disease, prior NAION). Elevated NAION Risk With Semaglutide The research team conducted an active-comparator, new-user, target trial emulation using nationwide VA data from 2018 to 2025
Waddingtons epigenetic landscape [1:23:00]
The choice among agents depends on factors including dosing frequency (daily versus weekly), route of administration, insurance coverage, patient preference, and comorbidity profile